Maze Therapeutics is a U.S. biotech advancing clinical-stage precision medicines for renal and metabolic diseases.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Learn more Maze Therapeutics, Inc. (NASDAQ:MAZE) shareholders will have a reason to smile today, with the analysts making substantial upgrades to this year's statutory forecasts. The analysts have ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced the U.S. Federal Trade Commission (FTC) has filed ...

Add Yahoo as a preferred source to see more of our stories on Google. Looking for a fun activity to do this fall? One of the country's best corn mazes is in Massachusetts, according to USA TODAY's ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Maze Therapeutics, a company translating genetic insights into new precision medicines, today announced the initiation of dosing in the company’s Phase 1 ...

Ready for an a-maze-ing fall adventure? We've found fifteen of the best corn mazes in the country to explore. During the day, you can navigate through a labyrinth of 10-foot-high stalks while trying ...